Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide as add-on to dopamine agonist in early Parkinson's disease (Study 015)
NCT00643045Phase 3Completed
- Sponsor
- Newron Pharmaceuticals
- Start
- Dec 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of safinamide in Parkinson's disease (PD), sponsored by Newron Pharmaceuticals. Started Dec 2004; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00643045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00643045.